Acclime Insights
Acclime Insights
Mar 23, 2022
Artificial Intelligence in Clinical Trials
Play • 49 min

This week Blair is joined by his colleague Tam Nguyen, who wears a number of different hats in his various roles. Along with being a Resident Director of Acclime Australia and supporting many life sciences companies with their clinical trial programs here in Australia, Tam is also Deputy Director of Clinical Research at St Vincent’s Hospital in Melbourne, holds a number of Associate Professorships and Adjunct Associate Professorships at RMIT, Monash University, and Melbourne University, and is also an expert advisor and board member of a number of organisations in Melbourne.

We are also very excited to be joined today by the wonderful Michelle Gallaher, who has generously agreed to share her experiences as an award-winning health technology entrepreneur, speaker and advocate. Michelle’s 25+ year career spans startups, biotech and pharma marketing roles, national medical research initiatives and leading a biotech peak-body. She is currently the CEO of the ASX-listed Opyl Ltd, which is an innovative tech company working at the intersection of social media, clinical trials, and artificial intelligence.

Search
Clear search
Close search
Google apps
Main menu